sulfamoxole has been researched along with Pyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckstein, E; Etzel, M; Wesenberg, W | 1 |
| Georgi, CE; Jarvis, WJ; Lewis, GE; Munger, HV; Reed, ND; Sehnert, KW | 1 |
2 other study(ies) available for sulfamoxole and Pyelitis
| Article | Year |
|---|---|
[Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123). 2. Results of a multicenter clinical trial of CN 3123 in infections of the kidneys and urinary tract].
Topics: Acute Disease; Adolescent; Adult; Child; Chronic Disease; Cystitis; Drug Combinations; Female; Humans; Male; Middle Aged; Prostatitis; Pyelitis; Pyelonephritis; Sulfamoxole; Surgical Wound Infection; Trimethoprim; Urinary Tract Infections | 1976 |
A bacteriologic and urologic evaluation of sulfamoxole.
Topics: Bacteria; Bacteriuria; Cystitis; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Microbial Sensitivity Tests; Proteus Infections; Pseudomonas Infections; Pyelitis; Staphylococcal Infections; Streptococcal Infections; Sulfamoxole | 1970 |